

67
Downloads
8
Episodes
Discover the secrets to staying youthful with Forever Young: Regen Leaders Share Anti-Aging Secrets! Join host Haydenn Harper as he interviews top regenerative wellness experts, uncovering cutting-edge anti-aging solutions, from non-invasive aesthetics to functional medicine. Tailored for adults, med spa professionals, and experts, insiders, entrepreneurs, and business owners in the anti-aging, longevity, med spa, and regenerative therapy industries, each episode delivers actionable insights to enhance vitality, beauty, and health. Tune in on Spotify, Apple Podcasts, and YouTube for inspiring stories and science-backed strategies to live your healthiest, most vibrant life.
Episodes

Saturday Sep 27, 2025
Ancient Wisdom Meets Modern Science: The Future of Longevity with Scotch McClure
Saturday Sep 27, 2025
Saturday Sep 27, 2025
Join host Haydenn Harper on Forever Young: Regen Leaders Share Anti-Aging Secrets as he welcomes Joshua "Scotch" McClure, CEO and Co-founder of Maxwell Biosciences ( https://maxwellbiosciences.com/ ), for an eye-opening discussion on longevity and health optimization. Scotch shares his journey from engineering to biotech, unveiling the LL-37 peptide’s role in slowing aging by repairing cells and fighting infections, and introduces Claromer™, a groundbreaking compound tackling antibiotic resistance. Explore practical anti-aging strategies like fasting and saunas, the science of reversing aging with stem cells, and how ancient wisdom from Ayurveda blends with modern innovations, offering listeners actionable insights to enhance their healthspan.
This podcast is sponsored by Harper Media. To learn how we can help your med spa, clinic, anti-aging, or wellness practice grow, visit us at https://theharpermedia.com/
Keywords: regenerative medicine, anti-aging, LL-37 peptide, Claromer™, antibiotic resistance, stem cell therapy, inflammation, longevity, health optimization, Ayurvedic medicine, fasting, saunas, heat shock proteins, personalized health, biotechnology innovations
No comments yet. Be the first to say something!